Intero Biosystems offers pharma companies to test drugs on mini-guts instead of animals
Denver startup Intero Biosystems, spun out of the University of Michigan, grows human gut organoids and sells them to pharma, biotech, food and chemical companies for testing compounds. The flagship product GastroScreen — organoids about 1 mm in size, shipped roughly 100 per tube. The company was founded in 2024, raised $2.3 million pre-seed and generated more than $400 thousand in revenue from the fourth quarter of last year through the third quarter of this year.
Sardor Qodirov
















